HIV/AIDS - Dominant player in chronic kidney disease

Ethnicity and Disease

Volumn 16, Issue SUPPL. 2, 2006, Pages

  Naicker, Saraladevi ^a,c   Thin, Maung Han ^b   Fabian, June ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Chronic kidney disease (CKD); End stage renal disease (ESRD); HIV associated nephropathy (HIVAN); HIV AIDS; Preventive strategies

Indexed keywords

ANTIRETROVIRUS AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; CORTICOSTEROID; CYCLOSPORIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICA; AFRICAN AMERICAN; CHRONIC KIDNEY DISEASE; DISEASE ASSOCIATION; GROUPS BY AGE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY FAILURE; REVIEW; SOCIOECONOMICS; STATISTICAL ANALYSIS; ADULT; CHILD; CHRONIC KIDNEY FAILURE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; RENAL REPLACEMENT THERAPY; VIROLOGY;

ADRENAL CORTEX HORMONES; ADULT; AIDS-ASSOCIATED NEPHROPATHY; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHILD; CYCLOSPORINE; HUMANS; KIDNEY FAILURE, CHRONIC; RENAL REPLACEMENT THERAPY;

EID: 33746099725     PISSN: 1049510X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. UNAIDS. Fact sheet on Africa. Available at: http://www.unaids.org/ bangkok2004/factsheets.html. Accessed on: 08/09/2005.
2. Gardenswartz MH, Lerner CW, Seligson GR, et al. Renal disease in patients with AIDS: a clinicopathological study. Clin Nephrol. 1984;21(4):197-204.
3. Rao TK, Fillipone EJ, Nicastri AD, et al. Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome. N Engl J Med. 1984;310:669-673.
4. Levin ML, Palella F, Shah S, Lerma E, Butter J, Kanwar YS. HIV-associated nephropathy occurring before HIV antibody seroconversion. Am J Kidney Dis. 2001;37(5):E39.
5. Kopp JB, Winkler C. HIV-associated nephropathy in African Americans. Kidney Int. 2003;83(Suppl):S43-S49.
6. Freedman BI, Soucie JM, Stone SM, Pegram S. Familial clustering of end-stage renal disease in blacks with HIV-associated nephropathy. Am J Kidney Dis. 1999;34(2):254-258.
7. Laradi A, Mallet A, Beaufils H, Allouache M, Martinez F. HIV-associated nephropathy: outcome and prognosis factors. J Am Soc Nephrol. 1998;9(12):2327-2335.
8. Bowden DW. Genetics of kidney disease. Kidney Int. 2003;83(Suppl):S8-S12.
9. Lightstone L. Preventing renal disease: the ethnic challenge in the United Kingdom. Kidney Int. 2005;97(Suppl):S78-S81.
10. Naicker S. End-stage renal disease in sub-Saharan and South Africa. Kidney Int. 2003;83(Suppl):S119-S122.
11. Ross MJ, Klotman PE. Recent progress in HIV-associated nephropathy. J Am Soc Nephrol. 2002;13(12):2997-3004.
12. Smith MC, Austen JL, Carey JT, et al. Prednisone improves renal function and proteinuria in human immunodeficiency associated nephropathy. Am J Med. 1996;101(1):41-48.
13. Eustace JA, Neuermberger E, Choi M, et al. Cohort study of the treatment of severe HIV-associated nephropathy with corticosteroids. Kidney Int. 2000;58(3):1253-1260.
14. Kimmel PL, Mishkin GJ, Umana WO. Captopril and renal survival in patients with HIV associated nephropathy. Am J Kidney Dis. 1996;28(2):202-208.
15. Burns GC, Paul SK, Toth IR, et al. Effect of angiotensin converting enzyme inhibition in HIV-associated nephropathy. J Am Soc Nephrol. 1997;8:1140-1146.
16. Wei A, Burns GC, Williams BA, et al. Long-term renal survival in HIV-associated nephropathy with angiotensin-converting enzyme inhibition. Kidney Int. 2003;64(4):1462-1471.
17. Ingulli E, Tejani A, Fikrig S, et al. Nephrotic syndrome associated with acquired immunodeficiency syndrome in children. J Pediatr. 1991;119(5):710-716.
18. Ifudu O, Rao TK, Tan CC, et al. Zidovudine is beneficial in human immunodeficiency virus associated nephropathy. Am J Nephrol. 1995;15(3):217-221.
19. Osborn L, Kunkel S, Naber GJ. Tumor necrosis factor-alpha and interleukin-1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor κ B. Proc Natl Acad Sci U S A. 1989;86(7):2336-2340.
20. Ahuja TS, Grady J, Khan S. Changing trends in the survival of dialysis patients with human immunodeficiency virus in the United States. J Am Soc Nephrol. 2002;13(7):1889-1993.
21. Stock PG, Roland ME, Carlson L, et al. Kidney and liver transplantation in human immunodeficiency virus infected patients: a pilot safety and efficacy study. Transplantation. 2003;76:370-375.
22. Abbott KC, Swanson SJ, Agodoa LY. Human immunodeficiency virus infection and kidney transplantation in the era of highly active antiretroviral therapy and modern immunosuppression. J Am Soc Nephrol. 2004;15:1633-1639.
23. Gupta SK, Eustace JA, Winston JA, et al. Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2005;40:1559-1585.